The LIFECODES LifeScreen and ID kits utilize the multiplex Luminex xMAP platform to screen for the presence of HLA antibodies and identify the specificity of the antibodies in positive samples.
LSA (Lifecodes Single Antigen) is designed to identify permissible allele level antigens in the highly sensitized patient. It also helps to identify those specificities that are masked in high PRA sera when tested on conventional identification panels.
DSA™ makes it possible to screen patients for the presence of antibodies directed against the HLA antigens of the donor. It is ideal for pre- and post-transplant monitoring.
